UK markets open in 7 hours 36 minutes
NIKKEI 225
27,807.98 +298.52 (+1.09%) HANG SENG
21,660.47 -297.93 (-1.36%) CRUDE OIL
73.58 +0.19 (+0.26%) GOLD FUTURES
1,876.30 -0.30 (-0.02%) DOW
33,926.01 -127.89 (-0.38%) BTC-GBP
19,116.83 -353.22 (-1.81%)
GlaxoSmithKline plc (GLAXF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 02:38PM EST
| Previous close | 17.28 |
| Open | 17.30 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 17.28 - 17.40 |
| 52-week range | 13.48 - 23.40 |
| Volume | |
| Avg. volume | 3,521 |
| Market cap | 71.917B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 12.98 |
| EPS (TTM) | 1.34 |
| Earnings date | N/A |
| Forward dividend & yield | 0.73 (4.22%) |
| Ex-dividend date | 23 Feb 2023 |
| 1y target est | N/A |
- PA Media: Money
GlaxoSmithKline tops new business gender equality index
The Equity Index 2022/23 produced by Lead 5050 ranked firms using official data on average salaries, bonuses, and pay.
- Zacks
GSK's Daprodustat Drug for Anemia Due to CKD Gets FDA Nod
GSK announces the FDA approval of daprodustat for the treatment of anemia due to chronic kidney disease (CKD) in adults on dialysis for at least four months.
- The Guardian
GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge
Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas
© 2023 Yahoo. All rights reserved.
